Overall, our results show that in healthy obese individuals, increased CD14+TLR4+ monocytes and circulatory VEGF levels associated independently with RHR, suggesting that RHR monitoring could be used as a non-invasive clinical indicator to identify healthy obese individuals at risk for inflammation and cardiovascular disease (Fig. 4). The gene discussed is CD14; the disease is cardiovascular disorder.